Back to Search Start Over

Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation.

Authors :
Fu, Yanxia
Zhang, Chen
Xie, Hui
Wu, Zisheng
Tao, Yurong
Wang, Ziyu
Gu, Meng
Wei, Panjian
Lin, Shuye
Li, Ruoran
He, Yuqi
Sheng, Jianqiu
Xu, Junfeng
Wang, Jinghui
Pan, Yuanming
Source :
Life Sciences. Dec2023, Vol. 334, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

Human umbilical cord mesenchymal stem cells (HUMSCs) have been documented to be effective for several immune disorders including inflammatory bowel diseases (IBD). However, it remains unclear how HUMSCs function in regulating immune responses and intestinal flora in the trinitrobenzene sulfonic acid (TNBS)-induced IBD model. We assessed the regulatory effects of HUMSCs on the gut microbiota, T lymphocyte subpopulations and related immune cytokines in the TNBS-induced IBD model. The mice were divided into the normal, TNBS, and HUMSC-treated groups. The effect of HUMSCs was evaluated by Hematoxylin and Eosin (H&E) staining, fluorescence-activated cell sorting (FACS), and enzyme-linked immunosorbent assay (ELISA) analyses. Metagenomics Illumina sequencing was conducted for fecal samples. We demonstrated that the disease symptoms and pathological changes in the colon tissues of TNBS-induced colitis mice were dramatically ameliorated by HUMSCs, which improved the gut microbiota and rebalanced the immune system, increasing the abundance of healthy bacteria (such as Lactobacillus murinus and Lactobacillus johnsonii), the Firmicutes/Bacteroidetes ratio, and the proportion of Tregs; the Th1/Th17 ratio was decreased. Consistently, the expression levels of IFN-γ and IL-17 were significantly decreased, and transforming growth factor-β1 (TGF-β1) levels were significantly increased in the plasma of colitis mice HUMSC injection. Our experiment revealed that HUMSCs mitigate acute colitis by regulating the rebalance of Th1/Th17/Treg cells and related cytokines and remodeling the gut microbiota, providing potential future therapeutic targets in IBD. • HUMSCs effectively alleviate TNBS-induced colitis symptoms in mice and improve TNBS-induced colon damage. • Injection of HUMSCs inhibits Th1/Th17 and promotes Treg to restore immune balance. • Gut bacteria, play an important role in regulating the balance of Th1/Th17 and Treg. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00243205
Volume :
334
Database :
Academic Search Index
Journal :
Life Sciences
Publication Type :
Academic Journal
Accession number :
173707013
Full Text :
https://doi.org/10.1016/j.lfs.2023.122189